# A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

> **NCT00000778** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 44 (—)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** Pyridoxine hydrochloride
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT00000778
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 44 (—)
- **Last updated:** 2008-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000778, "A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*